Wesana Health Announces Change to The Board of Directors
Wesana Health Holdings (CSE: WESA.X, OTC Pink: WSNAF) has announced significant changes to its board of directors. Mark Monaghan and Brendan Purdy have been appointed as new board members, while Robert Koffman and George Steinbrenner IV have resigned effective immediately.
Monaghan brings over 32 years of experience in investment banking and merchant banking. He currently serves as Managing Partner of a Latin American investment and advisory firm focused on growth companies and advises Kii Blockchain. His career includes completing billions in transactions for growth companies internationally. He holds degrees in economics and commerce from Queen's University and the University of Windsor.
Purdy joins as a practicing securities lawyer specializing in resource, life sciences, and technology sectors. His expertise includes public companies, capital markets, and mergers and acquisitions in Canadian junior equity markets. He holds a J.D. from the University of Ottawa and a Bachelor of Management and Organizational Studies from the University of Western Ontario.
Wesana Health Holdings (CSE: WESA.X, OTC Pink: WSNAF) ha annunciato cambiamenti significativi nel suo consiglio di amministrazione. Mark Monaghan e Brendan Purdy sono stati nominati nuovi membri del consiglio, mentre Robert Koffman e George Steinbrenner IV si sono dimessi con effetto immediato.
Monaghan porta con sé oltre 32 anni di esperienza nel settore bancario di investimento e nel merchant banking. Attualmente ricopre il ruolo di Managing Partner in una società di investimento e consulenza focalizzata sulle aziende in crescita in America Latina e consiglia Kii Blockchain. La sua carriera include la realizzazione di transazioni per miliardi di dollari per aziende in crescita a livello internazionale. Ha conseguito lauree in economia e commercio presso la Queen's University e l'University of Windsor.
Purdy si unisce come avvocato specializzato in titoli, con esperienza nei settori delle risorse, delle scienze della vita e della tecnologia. La sua competenza comprende aziende pubbliche, mercati dei capitali e fusioni e acquisizioni nei mercati azionari canadese. Ha conseguito un J.D. presso l'Università di Ottawa e una laurea in Management e Studi Organizzativi presso l'Università dell'Ontario occidentale.
Wesana Health Holdings (CSE: WESA.X, OTC Pink: WSNAF) ha anunciado cambios significativos en su junta directiva. Mark Monaghan y Brendan Purdy han sido nombrados nuevos miembros de la junta, mientras que Robert Koffman y George Steinbrenner IV han renunciado con efecto inmediato.
Monaghan aporta más de 32 años de experiencia en banca de inversión y banca comercial. Actualmente, se desempeña como Socio Gerente de una firma de inversión y asesoría centrada en empresas en crecimiento en América Latina y asesora a Kii Blockchain. Su carrera incluye la finalización de transacciones por miles de millones para empresas en crecimiento a nivel internacional. Tiene títulos en economía y comercio de la Queen's University y la Universidad de Windsor.
Purdy se une como abogado de valores en ejercicio, especializado en los sectores de recursos, ciencias de la vida y tecnología. Su experiencia incluye empresas públicas, mercados de capitales y fusiones y adquisiciones en los mercados de renta variable junior de Canadá. Tiene una J.D. de la Universidad de Ottawa y una licenciatura en Gestión y Estudios Organizacionales de la Universidad de Ontario Occidental.
Wesana Health Holdings (CSE: WESA.X, OTC Pink: WSNAF)는 이사회에 중대한 변화를 발표했습니다. Mark Monaghan와 Brendan Purdy가 새로운 이사로 임명되었으며, Robert Koffman과 George Steinbrenner IV는 즉시 사임했습니다.
Monaghan은 투자은행 및 머천트 뱅킹에서 32년 이상의 경력을 보유하고 있습니다. 그는 현재 성장 기업에 중점을 두는 라틴 아메리카 투자 및 자문 회사의 전무 파트너로 재직 중이며, Kii Blockchain의 자문 역할도 맡고 있습니다. 그의 경력에는 국제적으로 성장 기업을 위한 수십억 달러 규모의 거래가 포함됩니다. 그는 Queen's University와 Windsor University에서 경제학 및 상업학 학위를 취득했습니다.
Purdy는 자원, 생명과학 및 기술 분야를 전문으로 하는 증권 변호사로 합류합니다. 그의 전문 분야에는 캐나다 중소형 주식 시장의 상장 기업, 자본 시장 및 인수합병이 포함됩니다. 그는 오타와 대학교에서 J.D.를, 서부 온타리오 대학교에서 관리 및 조직 연구 학사를 취득했습니다.
Wesana Health Holdings (CSE: WESA.X, OTC Pink: WSNAF) a annoncé des changements significatifs au sein de son conseil d'administration. Mark Monaghan et Brendan Purdy ont été nommés nouveaux membres du conseil, tandis que Robert Koffman et George Steinbrenner IV ont démissionné avec effet immédiat.
Monaghan apporte plus de 32 ans d'expérience dans la banque d'investissement et le merchant banking. Il est actuellement Associé Gérant d'une société d'investissement et de conseil en Amérique latine, axée sur les entreprises en croissance, et conseille Kii Blockchain. Sa carrière inclut la gestion de transactions de plusieurs milliards pour des entreprises en croissance à l'international. Il détient des diplômes en économie et en commerce de la Queen's University et de l'University of Windsor.
Purdy rejoint l'équipe en tant qu'avocat des valeurs, spécialisé dans les secteurs des ressources, des sciences de la vie et de la technologie. Son expertise comprend les entreprises publiques, les marchés des capitaux ainsi que les fusions et acquisitions sur les marchés boursiers canadiens. Il détient un J.D. de l'Université d'Ottawa et un baccalauréat en gestion et études organisationnelles de l'Université de l'Ontario occidental.
Wesana Health Holdings (CSE: WESA.X, OTC Pink: WSNAF) hat bedeutende Änderungen im Vorstand bekannt gegeben. Mark Monaghan und Brendan Purdy wurden als neue Vorstandsmitglieder ernannt, während Robert Koffman und George Steinbrenner IV mit sofortiger Wirkung zurückgetreten sind.
Monaghan bringt über 32 Jahre Erfahrung im Investment- und Merchant Banking mit. Aktuell ist er geschäftsführender Partner einer auf Wachstumsunternehmen spezialisierten Investment- und Beratungsfirma für Lateinamerika und berät Kii Blockchain. Seine Karriere umfasst die Durchführung von Transaktionen in Milliardenhöhe für Wachstumsunternehmen auf internationaler Ebene. Er hat Abschlüsse in Wirtschaftswissenschaften und Handel von der Queen's University sowie der University of Windsor.
Purdy kommt als praktizierender Wertpapieranwalt, der auf die Sektoren Rohstoffe, Biowissenschaften und Technologie spezialisiert ist. Zu seinen Fachgebieten gehören öffentliche Unternehmen, Kapitalmärkte sowie Fusionen und Übernahmen im kanadischen Junior-Eigenkapitalmarkt. Er hat einen J.D. von der Universität Ottawa sowie einen Bachelor in Management und Organisationsstudien von der University of Western Ontario.
- Addition of experienced board member with 32+ years in investment banking
- New director brings expertise in growth companies and blockchain technology
- Addition of securities lawyer with expertise in life sciences and capital markets
- Loss of two board members including George Steinbrenner IV
Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - January 24, 2025) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTC Pink: WSNAF) (the "Company") is pleased to announce the appointment of Mark Monaghan and Brendan Purdy to its board of directors.
Mr. Monaghan has over 32 years of experience as an advisor, founder, and board member of investment banks and merchant banks. Mr. Monaghan is currently the Managing Partner of a Latin American based investment and advisory firm focused on growth companies, and an advisor to Kii Blockchain, a vertically integrated fintech company based in Colombia having the first blockchain ecosystem for emerging finance markets. Mr. Monaghan has served in senior executive roles with British and Canadian investment and advisory firms. Over the course of his career, he has completed billions of dollars of transactions for growth companies internationally. Mr. Monaghan holds a Bachelor of Arts in economics from Queen's University and a Bachelor of Commerce from the University of Windsor.
Mr. Purdy is a practicing securities lawyer focused on the resource, life sciences, and technology sectors. In his private practice, he has developed extensive experience with respect to public companies, capital markets, mergers and acquisitions, and other transactions fundamental to the Canadian junior equity markets. Prior to receiving his J.D. from the University of Ottawa, Mr. Purdy completed a Bachelor of Management and Organizational Studies degree from the University of Western Ontario, majoring in finance and administration.
The Company also announces the resignations of Robert Koffman and George Steinbrenner IV from their roles as Directors of the Company, effective immediately. The Company would like to thank Mr. Koffman and Mr. Steinbrenner for their contributions to the Company during their tenure.
ON BEHALF OF THE BOARD
Daniel Carcillo, Chairman and Chief Executive Officer
Phone: 702-329-8038
About Wesana Health
Wesana was an emerging life sciences company championing the development and delivery of psychedelic and naturally-sourced therapies to treat traumatic brain injury. The Company was developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma. It discontinued the psychedelics business and disposed of the assets in 2023 and is now looking for new business opportunities.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/238396
FAQ
Who are the new board members appointed to Wesana Health (WSNAF) in January 2024?
What experience does Mark Monaghan bring to Wesana Health's board (WSNAF)?
What is Brendan Purdy's background as new Wesana Health (WSNAF) director?
Which board members resigned from Wesana Health (WSNAF) in January 2024?
